Essentials of SGLT2 Inhibitors in Diabetes

  • Miles Fisher
  • Gerard McKay

Table of contents

  1. Front Matter
    Pages i-xi
  2. Jenna Cowan
    Pages 1-12
  3. Gerard McKay, Rachel Livingstone
    Pages 13-35

About this book


Written by experts in the field, this clinical handbook explores the novel SGLT2 drug class for the treatment of diabetes. This book includes evidence-based guidelines, major clinical trials, and a discussion of treatment options currently available, as well as those currently in development. Essentials of SGLT2 Inhibitors is an ideal educational resource for busy medical professionals who need to stay up-to-date with diabetes treatment advances in order to provide the best possible clinical care for their patients.


Diabetes SGLT2 Sodium-glucose transport proteins Type 2 diabetes canagliflozin dapagliflozin empagliflozin

Authors and affiliations

  • Miles Fisher
    • 1
  • Gerard McKay
    • 2
  1. 1.Glasgow Royal Infirmary GlasgowUnited Kingdom
  2. 2.Glasgow Royal Infirmary GlasgowUnited Kingdom

Bibliographic information

  • DOI
  • Copyright Information Springer International Publishing Switzerland 2017
  • Publisher Name Adis, Cham
  • eBook Packages Medicine
  • Print ISBN 978-3-319-43294-6
  • Online ISBN 978-3-319-43296-0
  • Buy this book on publisher's site